Ifinwil Norgine Pty Ltd
Product name
Ifinwil
Sponsor
Accepted date
Apr-2024
Active ingredients
eflornithine hydrochloride
Proposed indication
For the treatment of neuroblastoma.
Application type
A (new medicine)
Publication date
Apr-2024
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.